Stephen M. Perry

Stephen is the CEO and founder of the contract development and manufacturing firm, Kymanox. He has over 20 years of cGMP biopharma manufacturing experience as a process engineer, project manager, and regulatory advisor. Before starting Kymanox, Stephen held various leadership roles supporting successful scale-up, start-up and commercialization initiatives at M+W Group, Abbott Laboratories, Covance Biotechnology Services, Diosynth Biotechnology and Human Genome Sciences. Stephen graduated with high honors with a degree in Chemical Engineering from the University of Notre Dame. He has also studied at the graduate level at Purdue University. Stephen speaks regularly as an industry expert on technology transfer, project management, risk management, and validation.